                         SEQUENCE LISTING

<110>  ARMO BioSciences, Inc.
       Mumm, John
       VAN VLASSELAER, PETER
 
<120>  METHOD FOR ASSESSING PROTEIN IDENTITY AND STABILITY

<130>  ARMO-008WO

<150>  US 61/836,034
<151>  2013-06-17

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  178
<212>  PRT
<213>  Homo sapiens

<400>  1

Met His Ser Ser Ala Leu Leu Cys Cys Leu Val Leu Leu Thr Gly Val 
1               5                   10                  15      


Arg Ala Ser Pro Gly Gln Gly Thr Gln Ser Glu Asn Ser Cys Thr His 
            20                  25                  30          


Phe Pro Gly Asn Leu Pro Asn Met Leu Arg Asp Leu Arg Asp Ala Phe 
        35                  40                  45              


Ser Arg Val Lys Thr Phe Phe Gln Met Lys Asp Gln Leu Asp Asn Leu 
    50                  55                  60                  


Leu Leu Lys Glu Ser Leu Leu Glu Asp Phe Lys Gly Tyr Leu Gly Cys 
65                  70                  75                  80  


Gln Ala Leu Ser Glu Met Ile Gln Phe Tyr Leu Glu Glu Val Met Pro 
                85                  90                  95      


Gln Ala Glu Asn Gln Asp Pro Asp Ile Lys Ala His Val Asn Ser Leu 
            100                 105                 110         


Gly Glu Asn Leu Lys Thr Leu Arg Leu Arg Leu Arg Arg Cys His Arg 
        115                 120                 125             


Phe Leu Pro Cys Glu Asn Lys Ser Lys Ala Val Glu Gln Val Lys Asn 
    130                 135                 140                 


Ala Phe Asn Lys Leu Gln Glu Lys Gly Ile Tyr Lys Ala Met Ser Glu 
145                 150                 155                 160 


Phe Asp Ile Phe Ile Asn Tyr Ile Glu Ala Tyr Met Thr Met Lys Ile 
                165                 170                 175     


Arg Asn 
        


<210>  2
<211>  160
<212>  PRT
<213>  Homo sapiens

<400>  2

Ser Pro Gly Gln Gly Thr Gln Ser Glu Asn Ser Cys Thr His Phe Pro 
1               5                   10                  15      


Gly Asn Leu Pro Asn Met Leu Arg Asp Leu Arg Asp Ala Phe Ser Arg 
            20                  25                  30          


Val Lys Thr Phe Phe Gln Met Lys Asp Gln Leu Asp Asn Leu Leu Leu 
        35                  40                  45              


Lys Glu Ser Leu Leu Glu Asp Phe Lys Gly Tyr Leu Gly Cys Gln Ala 
    50                  55                  60                  


Leu Ser Glu Met Ile Gln Phe Tyr Leu Glu Glu Val Met Pro Gln Ala 
65                  70                  75                  80  


Glu Asn Gln Asp Pro Asp Ile Lys Ala His Val Asn Ser Leu Gly Glu 
                85                  90                  95      


Asn Leu Lys Thr Leu Arg Leu Arg Leu Arg Arg Cys His Arg Phe Leu 
            100                 105                 110         


Pro Cys Glu Asn Lys Ser Lys Ala Val Glu Gln Val Lys Asn Ala Phe 
        115                 120                 125             


Asn Lys Leu Gln Glu Lys Gly Ile Tyr Lys Ala Met Ser Glu Phe Asp 
    130                 135                 140                 


Ile Phe Ile Asn Tyr Ile Glu Ala Tyr Met Thr Met Lys Ile Arg Asn 
145                 150                 155                 160 


<210>  3
<211>  274
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  3

Val Ile Leu Pro Asn Asn Asp Arg His Gln Ile Thr Asp Thr Thr Asn 
1               5                   10                  15      


Gly His Tyr Ala Pro Val Thr Tyr Ile Gln Val Glu Ala Pro Thr Gly 
            20                  25                  30          


Thr Phe Ile Ala Ser Gly Val Val Val Gly Lys Asp Thr Leu Leu Thr 
        35                  40                  45              


Asn Lys His Val Val Asp Ala Thr His Gly Asp Pro His Ala Leu Lys 
    50                  55                  60                  


Ala Phe Pro Ser Ala Ile Asn Gln Asp Asn Tyr Pro Asn Gly Gly Phe 
65                  70                  75                  80  


Thr Ala Glu Gln Ile Thr Lys Tyr Ser Gly Glu Gly Asp Leu Ala Ile 
                85                  90                  95      


Val Lys Phe Ser Pro Asn Glu Gln Asn Lys His Ile Gly Glu Val Val 
            100                 105                 110         


Lys Pro Ala Thr Met Ser Asn Asn Ala Glu Thr Gln Val Asn Gln Asn 
        115                 120                 125             


Ile Thr Val Thr Gly Tyr Pro Gly Asp Lys Pro Val Ala Thr Met Trp 
    130                 135                 140                 


Glu Ser Lys Gly Lys Ile Thr Tyr Leu Lys Gly Glu Ala Met Gln Tyr 
145                 150                 155                 160 


Asp Leu Ser Thr Thr Gly Gly Asn Ser Gly Ser Pro Val Phe Asn Glu 
                165                 170                 175     


Lys Asn Glu Val Ile Gly Ile His Trp Gly Gly Val Pro Asn Glu Phe 
            180                 185                 190         


Asn Gly Ala Val Phe Ile Asn Glu Asn Val Arg Asn Phe Leu Lys Gln 
        195                 200                 205             


Asn Ile Glu Asp Ile His Phe Ala Asn Asp Asp Gln Pro Asn Asn Pro 
    210                 215                 220                 


Asp Asn Pro Asp Asn Pro Asn Asn Pro Asp Asn Pro Asn Asn Pro Asp 
225                 230                 235                 240 


Glu Pro Asn Asn Pro Asp Asn Pro Asn Asn Pro Asp Asn Pro Asp Asn 
                245                 250                 255     


Gly Asp Asn Asn Asn Ser Asp Asn Pro Asp Ala Ala His His His His 
            260                 265                 270         


His His 
        


<210>  4
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  4

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  5
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  5

Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg 
1               5                   10          


<210>  6
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  6

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  7
<211>  33
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  7

Lys Ala Leu Ala Trp Glu Ala Lys Leu Ala Lys Ala Leu Ala Lys Ala 
1               5                   10                  15      


Leu Ala Lys His Leu Ala Lys Ala Leu Ala Lys Ala Leu Lys Cys Glu 
            20                  25                  30          


Ala 
    


<210>  8
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  8

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  9
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  9

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  10
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  10

Arg Lys Lys Arg Arg Gln Arg Arg 
1               5               


<210>  11
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  11

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  12
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  12

Thr His Arg Leu Pro Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  13
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  13

Gly Gly Arg Arg Ala Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  14
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  amino acids 1-5 may be repeated n times where n is an an integer 
       of at least one

<400>  14

Gly Ser Gly Gly Ser 
1               5   


<210>  15
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  amino acids 1-4 may be repeated n times where n is an an integer 
       of at least one

<400>  15

Gly Gly Gly Ser 
1               


<210>  16
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  16

Gly Gly Ser Gly 
1               


<210>  17
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  17

Gly Gly Ser Gly Gly 
1               5   


<210>  18
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  18

Gly Ser Gly Ser Gly 
1               5   


<210>  19
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  19

Gly Ser Gly Gly Gly 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  20

Gly Gly Gly Ser Gly 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic polypeptide

<400>  21

Gly Ser Ser Ser Gly 
1               5   


